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Cilia mediate mechanosensing 
in bone cells by a different 
mechanism than in kidney cells
Mammalian cells can detect mechanical signals, and such 
signals play important roles in proliferation, diﬀerentiation, 
and pathology. In most tissues, however, the cellular 
mechanosensors are unknown. Primary cilia are solitary, 
immotile, microtubule-based organelles that grow from the 
centrosome and project from the cell surface in many ver-
tebrate tissues. Primary cilia possess receptors for signaling 
molecules such as somatostatin and platelet-derived growth 
factor but also function as ﬂow sensors, particularly in kid-
ney tubule epithelial cells. When mechanically stimulated, 
primary cilia in kidney cells cause Ca2+ inﬂux through the 
stretch-sensitive Ca2+ channel polycystin 2, triggering intra-
cellular Ca2+ release. Mutations in polycystin 2, or mutations 
that result in abnormal cilia, cause polycystic kidney disease 
in humans and mice.
Of the many tissues sensitive to mechanical stimuli, bone 
is an exquisitely mechanosensitive organ, altering its mor-
phology and density in response to external loads. In addi-
tion, lack of mechanical stimulation has been linked to bone 
loss in osteoporosis. To elucidate the mechanism whereby 
mechanical stimuli are translated into osteogenic and bone 
resorptive responses, Malone et al. examined whether cilia 
act as mechanosensors in bone cells (Figure). Osteoblasts and 
osteocytes responded to dynamic ﬂuid ﬂow with increases 
in gene expression and cytokine release. The authors showed 
that while exposure increased osteopontin mRNA, abroga-
tion of cilium formation and function prevented this eﬀect. 
Surprisingly, they found that cilium-mediated mechanotrans-
duction in bone diﬀered from that described in other tissues, 
particularly kidney epithelium. Flow-induced Ca2+ response 
in bone cells was independent of extracellular calcium entry 
and polycystin 2, and bone cells lacking primary cilia still 
exhibited Ca2+ ﬂux during ﬂow. These results indicate that 
primary cilia act as ﬂow sensors in bone cells by a mechanism 
that diﬀers from that of kidney cells. (Proc Natl Acad Sci USA 
2007; 104: 13325–13330)
Juan Oliver
Augmented Wnt signaling in 
accelerated aging
It is well known that advanced age is associated with multiple 
problems, including a decline of regenerative potential of many 
organs, such as the kidney and skeletal muscle. Resident and 
circulating stem and progenitor cells are critical for ongoing main-
tenance and repair of many organs, and it has been postulated that 
their depletion or dysfunction might contribute to aging.
To test this, Liu et al. examined stem-cell dynamics in a genetic 
model of accelerated aging. They used mice lacking klotho expres-
sion, termed Klotho mice, which have a shortened lifespan and 
exhibit a number of early-onset age-related changes, including 
arteriosclerosis, decreased fertility, and skin atrophy. Klotho is 
a transmembrane protein with a large extracellular domain that 
shares similarity to family I glycosidases. In addition to being cell-
associated, the extracellular portion of klotho is secreted and can 
be detected in the circulation; it is generally believed that secreted 
klotho is the form that most likely mediates the protein’s longev-
ity eﬀects. Analysis of various tissues and organs from young 
Klotho mice revealed a decrease in stem-cell number (Figure) 
and an increase in progenitor-cell senescence. Because klotho is a 
secreted protein, the authors postulated that klotho might interact 
with other soluble mediators of stem cells. They found that klotho 
bound to various Wnt family members. In a cell-culture model, 
the Wnt–klotho interaction suppressed Wnt biological activity. 
Tissues and organs from klotho-deﬁcient animals had increased 
Wnt signaling, and ectopic expression of klotho antagonized the 
activity of endogenous and exogenous Wnt. Both in vitro and 
in vivo, continuous Wnt exposure triggered accelerated cellular 
senescence. Thus, klotho appears to be a Wnt antagonist, and 
Wnt proteins have an unexpected role in mammalian aging. 
(Science 2007; 317: 803–806)
Juan Oliver
Wnt signaling during aging 
alters muscle stem-cell fate and 
increases fibrosis
Aging of skeletal muscle is characterized by increased ﬁbrosis 
and impaired muscle regenerative potential. This is manifested 
Primary cilia project from the apical surface of bone cells and bend 
during fluid flow.
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Label-retaining cells (that is, low-cycling cells) within the skin follicles of 80-
day-old wild-type or Klotho mice are a convenient method to identify stem 
cells within their niche.
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by a replacement of muscle by ﬁbrous connective tissue and 
adipose tissue. Similarly, in the muscular dystrophies, pro-
gressive muscle ﬁbrosis also occurs with age. Exposure to a 
youthful systemic environment can enhance the regeneration 
of aged muscle, an eﬀect that is, at least in part, mediated by 
restoration of normal signaling of the Delta–Notch pathway. 
Therefore, Brack et al. tested whether exposure of old tissue 
to a youthful systemic environment, established by parabiotic 
pairings of old animals to young animals (heterochronic pair-
ings), might also reduce the ﬁbrotic response of old muscle. 
They found reduced collagen deposition in regenerating 
areas in muscles of aged mice in heterochronic pairings as 
compared with aged mice in isochronic pairings (pairings of 
mice of the same age). This was accompanied by enhanced 
proliferation of myogenic progenitors. Conversely, collagen 
deposition increased and progenitor proliferation decreased 
in young partners of heterochronic pairings as compared with 
young partners in isochronic pairings. Thus, systemic inﬂu-
ences that change with age are important in mediating the 
ﬁbrotic responses of aged tissues.
The authors also found that muscle stem cells (satellite 
cells) from aged mice tended to convert from a myogenic to 
a ﬁbrogenic lineage as they began to proliferate and that this 
conversion was mediated by factors in the systemic environ-
ment of the old animals. Interestingly, this lineage conversion 
was associated with activation of the canonical Wnt signal-
ing pathway in aged myogenic progenitors, and it could be 
suppressed by Wnt inhibitors. In addition, reduced ﬁbrosis 
occurred in aged regenerating muscle injected with Dick-
kopf-1 (DKK1), a Wnt antagonist, whereas no change was 
observed in young muscle similarly treated (Figure). Fur-
thermore, components of sera from aged mice that bind to 
the Frizzled family of proteins, which are Wnt receptors, may 
account for the elevated Wnt signaling in aged cells. These 
results indicate that the Wnt signaling pathway appears to 
play a critical role in tissue-speciﬁc stem-cell aging and in the 
increase in tissue ﬁbrosis with age. These ﬁndings also dem-
onstrate that, with age, the systemic environment is less eﬀec-
tive in maintaining the myogenic fate of muscle stem cells. 
Instead, it facilitates conversion to a ﬁbrogenic fate. In vivo, 
this conversion is associated with impaired muscle regenera-
tion and an enhanced ﬁbrotic response. (Science 2007; 317: 
807–810)
Juan Oliver
Calcium alone or combined with 
vitamin D prevents fractures and 
bone loss in older people
Calcium alone, or in combination with vitamin D, has been 
suggested as an inexpensive treatment to prevent osteoporosis-
related bone loss and fractures, with low treatment costs. How-
ever, substantial uncertainty exists regarding its eﬃcacy in 
lowering the fracture rate. Data from earlier clinical trials show 
that calcium reduced fracture rates, but this ﬁnding was not 
conﬁrmed in subsequent multicenter trials. Moreover, results 
from metaanalyses have been inconsistent.
In review of the relevant evidence, Tang et al. conducted 
a metaanalysis that included all the randomized trials in 
which calcium, or calcium in combination with vitamin D, 
was used to prevent fracture and osteoporotic bone loss. They 
identiﬁed 29 randomized trials (n = 63,897) using electronic 
databases that recruited people aged 50 years or older, sup-
plemented by a hand-search of reference lists, review articles, 
and conference abstracts. The main outcomes were fractures 
of all types and percentage change of bone-mineral density 
from baseline. Data were pooled by use of a random-eﬀect 
model. In trials that reported fracture as an outcome (17 trials, 
n = 52,625), treatment was associated with a 12% risk reduc-
tion in fractures of all types (risk ratio 0.88, 95% conﬁdence 
interval 0.83–0.95; P = 0.0004). In trials that reported bone-
mineral density as an outcome (23 trials, n = 41,419), the treat-
ment was associated with a reduced rate of bone loss of 0.54% 
(0.35–0.73; P < 0.0001) at the hip and 1.19% (0.76–1.61; P < 
0.0001) in the spine. The fracture-risk reduction was signiﬁ-
cantly greater (24%) in trials in which the compliance rate was 
high (P < 0.0001). The treatment eﬀect was better with calcium 
doses of 1,200 mg or more than with doses less than 1,200 mg 
(0.80 versus 0.94; P = 0.006) and better with vitamin D doses 
of 800 IU or more than with doses less than 800 IU (0.84 versus 
0.87; P = 0.03).
The authors conclude that calcium supplementation, alone 
or in combination with vitamin D, is eﬀective in the preven-
tive treatment of osteoporotic fracture. Over an average treat-
ment duration of 3.5 years, the risk of fracture was reduced 
and was accompanied by a reduction of bone loss at the hip 
and spine. The fracture-risk reduction was greater in indi-
viduals who were elderly, lived in institutions, had a low body 
weight, had a low calcium intake, or were at a high baseline 
risk than it was in others. The treatment eﬀect was consistent 
irrespective of sex, fracture sites, or history of previous frac-
ture. Moreover, the treatment was similarly eﬀective whether 
the person used calcium or calcium in combination with 
vitamin D supplementation. However, the treatment was less 
eﬀective if compliance was poor. For calcium-only supple-
mentation, a minimum dose of 1,200 mg is needed for best 
therapeutic eﬀect. For calcium in combination with vitamin 
D supplementation, a minimum dose of 800 IU of vitamin D 
is recommended. (Lancet 2007; 370: 657–666)
Marc De BroeEffects of Wnt inhibition on fibrosis in regenerating muscle.
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